Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain

Journal of Molecular Endocrinology

Volumn 34, Issue 3, 2005, Pages 793-807

  Li, J H ^d   Sicard, F ^a   Salam, M A ^d   Baek, M ^d   LePrince, J ^a   Vaudry, H ^a   Kim, K ^b   Kwon, H B ^d   Seong, J Y ^c  

^a UNIVERSITÉ DE ROUEN   (France)

^b Seoul National University   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; COMPLEMENTARY DNA; CYCLIC AMP DEPENDENT PROTEIN KINASE; NEUROTENSIN RECEPTOR; PROTEIN KINASE C; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; BULLFROG; CALCIUM CELL LEVEL; CELL CULTURE; CONTROLLED STUDY; DNA ISOLATION; DNA LIBRARY; ENZYME ACTIVITY; GENE AMPLIFICATION; GENE EXPRESSION; GENETIC CODE; HUMAN; MOLECULAR CLONING; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RNA ISOLATION; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SPECIES DIFFERENCE; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; LIGANDS; MOLECULAR SEQUENCE DATA; RANA CATESBEIANA; RECEPTORS, NEUROTENSIN; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 21344474357     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01709     Document Type: Article

References (55)

1. 318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation. Endocrinology 137 655-662.
2. Bello AR, Kah O, Tramu G & Conlon JM 1993 Purification and primary structure of alligator neurotensin. Peptides 14 1055-1058.
3. Belmeguenai A, Vaudry H, Leprince J, Vivet B, Cavelier F, Martinez J & Louiset E 2000 Neurotensin modulates the electrical activity of frog pituitary melanotropes via activation of a G-protein-coupled receptor pharmacologically related to both the NTS1 and NTS2 receptors of mammals. Neuroendocrinology 72 379-391.
4. 3H]SR 142948A, in the rat brain. European Journal of Pharmacology 343 67-77.
5. Botto JM, Guillemare E, Vincent JP & Mazella J 1997 Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor. Neuroscience Letters 223 193-196.
6. Botto JM, Chabry J, Sarret P, Vincent JP & Mazella J 1998 Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism. Biochemical and Biophysical Research Communications 243 585-590.
7. Carraway RE & Bhatnagar YM 1980 Isolation, structure and biological activity of chicken intestinal neurotensin. Peptides 1 167-174.
8. Carraway RE & Leeman SE 1973 The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. Journal of Biological Chemistry 248 6854-6861.
9. 2+-dependent adenylyl cyclase(s). Molecular and Cellular Endocrinology 144 47-57.
10. Chabry J, Labbé-Jullié C, Gully D, Kitabgi P, Vincent JP & Mazella J 1994 Stable expression of the cloned rat brain neurotensin receptor into fibroblasts: binding properties, photoaffinity labeling, transduction mechanisms, and internalization. Journal of Neurochemistry 63 19-27.
11. Chabry J, Botto JM, Nouel D, Beaudet A, Vincent JP & Mazella J 1995 Thr-422 and Tyr-424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor. Journal of Biological Chemistry 270 2439-2442.
12. Chalon P, Vita N, Kaghad M, Guillemot M, Bonnin J, Delpech B, Le Fur G, Ferrara P & Caput D 1996 Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Letters 386 91-94.
13. Conlon JM, Adrian TE & Secor SM 1997 Tachykinins (substance P, neurokinin A and neuropeptide γ and neurotensin from the intestine of the Burmese python, Python molurus. Peptides 18 1505-1510.
14. Dal Farra C, Sarret P, Navarro V, Botto JM, Mazella J & Vincent JP 2001 Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines. International Journal of Cancer 92 503-509.
15. Desrues L, Tonon MC, Leprince J, Vaudry H & Conlon JM 1998 Isolation, primary structure, and effects on α-melanocyte-stimulating hormone release of frog neurotensin. Endocrinology 139 4140-4146.
16. Dubuc I, Sarret P, Labbe-Jullie C, Botto JM, Honore E, Bourdel E, Martinez J, Costentin J, Vincent JP, Kitabgi P et al. 1999 Identification of the receptor subtype involved in the analgesic effect of neurotensin. Journal of Neuroscience 19 503-510.
17. Gailly P, Najimi M & Hermans E 2000 Evidence for the dual coupling of the rat neurotensin receptor with pertussis toxin-sensitive and insensitive G-proteins. FEBS Letters 483 109-113.
18. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard JC, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A et al. 1993 Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. PNAS 90 65-69.
19. Gully D, Labeeuw B, Boigegrain R, Oury-Donat F, Bachy A, Poncelet M, Steinberg R, Suaud-Chagny MF, Santucci V, Vita N et al. 1997 Bio-chemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 280 802-812.
20. Hermans E, Gailly P, Octave JN & Maloteaux JM 1994 Rapid desensitization of agonist-induced calcium mobilization in transfected PC12 cells expressing the rat neurotensin receptor. Biochemical and Biophysical Research Communications 198 400-407.
21. Kenakin T 2001 Inverse, protean, and ligand-selective agonism: matters of receptor conformation. FASEB Journal 15 598-611.
22. Kitabgi P 2002 Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes. Current Opinions in Drug Discovery and Development 5 764-776.
23. Kitabgi P, Carraway R & Leeman SE 1976 Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin. Journal of Biological Chemistry 251 7053-7058.
24. + regulation of agonist binding but does not alter receptor-G protein association. Molecular Pharmacology 44 380-384.
25. Labbé-Jullié C, Dubuc I, Brouard A, Doulut S, Bourdel E, Pélaprat D, Mazella J, Martinez J, Rostène W, Costentin J et al. 1994 In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. Journal of Pharmacology and Experimental Therapeutics 268 328-336.
26. Labbé-Jullié C, Barroso S, Nicolas-Eteve D, Reversat JL, Botto JM, Mazella J, Bernassau JM & Kitabgi P 1998 Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist. Journal of Biological Chemistry 273 16351-16337.
27. Maeno H, Yamada K, Santo-Yamada Y, Aoki K, Sun YJ, Sato E, Fukushima T, Ogura H, Araki T, Kamichi S et al. 2004 Comparison of mice deficient in the high- or low-affinity neurotensin receptors, Ntsr1 or Ntst2, reveals a novel function for Ntsr2 in thermal nociception. Brain Research 998 122-129.
28. Martin S, Botto JM, Vincent JP & Mazella J 1999 Pivotal role of an aspartate residue in sodium sensitivity and coupling to G proteins of neurotensin receptors. Molecular Pharmacology 55 210-215.
29. Martin S, Vincent JP & Mazella J 2003 Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. Journal of Neuroscience 23 1198-1205.
30. Mazella J, Botto JM, Guillemare E, Coppola T, Sarret P & Vincent JP 1996 Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. Journal of Neuroscience 16 5613-5620.
31. Mazella J, Zsurger N, Navarro V, Chabry J, Kaghad M, Caput D, Ferrara P, Vita N, Gully D, Maffrand JP et al. 1998 The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. Journal of Biological Chemistry 273 26273-26276.
32. McCann SM & Vijayan E 1992 Control of anterior pituitary hormone secretion by neurotensin. Annals of the New York Academy of Sciences 668 287-297.
33. McMahon BM, Boules M, Warrington L & Richelson E 2002 Neurotensin analogs: indications for use as potential antipsychotic compounds. Life Sciences 70 1101-1119.
34. Mitchell R, McCulloch D, Lutz E, Johnson M, MacKenzie C, Fennell M, Fink G, Zhou W & Sealfors SC 1998 Rhodopsin-family receptors associate with small G proteins to activate phospholipase D. Nature 392 411-414.
35. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, Nielsen MS, Jacobsen C, Kliemannel M, Schwarz E, Willnow TE et al. 2004 Sortilin is essential for proNGF-induced neuronal cell death. Nature 427 843-848.
36. Oh DY, Wang L, Ahn RS, Park JY, Seong JY & Kwon HB 2003 Differential G protein coupling preference of mammalian and nonmammalian gonadotropin-releasing hormone receptors. Molecular and Cellular Endocrinology 205 89-98.
37. Pang YP, Cusack B, Groshan K & Richelson E 1996 Proposed ligand binding site of the transmembrane receptor for neurotensin(8-13). Journal of Biological Chemistry 271 15060-15068.
38. Remaury A, Vita N, Gendreau S, Jung M, Arnone M, Poncelet M, Culouscou JM, Le Fur G, Soubrie P, Caput D et al. 2002 Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia. Brain Research 953 63-72.
39. Richard F, Barroso S, Martinez J, Labbe-Jullie C & Kitabgi P 2001 Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Molecular Pharmacology 60 1392-1398.
40. Rostène WH & Alexander MJ 1997 Neurotensin and neuroendocrine regulation. Frontiers in Neuroendocrinology 18 115-173.
41. Sadoul JL, Mazella J, Amar S, Kitabgi P & Vincent JP 1984 Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors. Biochemical and Biophysical Research Communications 120 812-819.
42. Sarret P, Gendron L, Kilian P, Nguyen HM, Gallo-Payet N, Payet MD & Beaudet A 2002 Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells. Journal of Biological Chemistry 277 36233-36243.
43. Sealfon SC, Weinstein H & Millar RP 1997 Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocrine Reviews 18 180-205.
44. Seong JY, Wang L, Oh DY, Yun O, Maiti K, Li JH, Soh JM, Choi HS, Kim K, Vaudry H et al. 2003 Ala/Thr(201) in extracellular loop 2 and leu/phe(290) in transmembrane domain 6 of type 1 frog gonadotropin-releasing hormone receptor confer differential ligand sensitivity and signal transduction. Endocrinology 144 454-466.
45. Shaw C, McKay DM, Halton DW, Thim L & Buchanan KD 1992 Isolation and primary structure of an amphibian neurotensin. Regulatory Peptides 38 23-31.
46. Sicard F, Vaudry H, Braun B, Chartrel N, Leprince J, Conlon JM & Delarue C 2000 Immunohistochemical localization, biochemical characterization, and biological activity of neurotensin in the frog adrenal gland. Endocrinology 141 2450-2457.
47. Somai S, Gompel A, Rostene W & Forgez P 2002 Neurotensin counteracts apoptosis in breast cancer cells. Biochemical and Biophysical Research Communications 295 482-488.
48. Tanaka K, Masu M & Nakanishi S 1990 Structure and functional expression of the cloned rat neurotensin receptor. Neuron 4 847-854.
49. Vincent JP, Mazella J & Kitabgi P 1999 Neurotensin and neurotensin receptors. Trends in Pharmacological Sciences 20 302-309.
50. Vita N, Laurent P, Lefort S, Chalon P, Dumont X, Kaghad M, Gully D, Lefur G, Ferrara P & Caput D 1993 Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Letters 317 139-142.
51. Vita N, Oury-Donat F, Chalon P, Guillemot M, Kaghad M, Bachy A, Thurneyssen O, Garcia S, Poinot-Chazel C, Casellas P et al. 1698 Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. European Journal of Pharmacology 360 263-272.
52. Watson MA, Yamada M, Yamada M, Cusack B, Veverka K, Bolden-Watson C & Richelson E 1992 The rat neurotensin receptor expressed in Chinese hamster ovary cells mediates the release of inositol phosphates. Journal of Neurochemistry 59 1967-1970.
53. Yamada M, Yamada M, Watson MA & Richelson E 1993 Neurotensin stimulates cyclic AMP formation in CHO-rNTR-10 cells expressing the cloned rat neurotensin receptor. European Journal of Pharmacology 244 99-101.
54. 2 receptor expressed in Chinese hamster ovary cells. Life Sciences 62 375-380.
55. Yamauchi R, Usui H, Yunden J, Takenaka Y, Tani F & Yoshikawa M 2003 Characterization of β-lactotensin, a bioactive peptide derived from bovine β-lactoglobulin, as a neurotensin agonist. Bioscience, Biotechnology, and Biochemistry 67 940-943.